In the U.S. sex selection by pre-implantation genetic diagnosis (PGD) is growing in popularity. Dr. Jeffrey Steinberg, the medical director of the Fertility Institutes says this about using technology for sex selection, “It performs a much desired service. We are making people happy.” 42% of U.S. clinics offer PGD for non medically indicated sex selection. Almost 50% of the clinics said they’d offer this service for second and subsequent children. Was it Hippocrates who said, “physician-make the customer happy”?
Author Profile
- Jennifer Lahl, MA, BSN, RN, is founder and president of The Center for Bioethics and Culture Network. Lahl couples her 25 years of experience as a pediatric critical care nurse, a hospital administrator, and a senior-level nursing manager with a deep passion to speak for those who have no voice. Lahl’s writings have appeared in various publications including Cambridge University Press, the San Francisco Chronicle, the Dallas Morning News, and the American Journal of Bioethics. As a field expert, she is routinely interviewed on radio and television including ABC, CBS, PBS, and NPR. She is also called upon to speak alongside lawmakers and members of the scientific community, even being invited to speak to members of the European Parliament in Brussels to address issues of egg trafficking; she has three times addressed the United Nations during the Commission on the Status of Women on egg and womb trafficking.
Latest entries
FeaturedSeptember 9, 2024Don’t Make Claims Using Outdated Data
BioethicsMay 16, 2024The Ethics of Transplantation Medicine
infertilityApril 23, 2024The Rise of International Gestational Surrogacy in the U.S.
Assisted Reproductive TechnologyApril 16, 2024Founder Jennifer Lahl’s Speech on Surrogacy to the Casablanca Declaration
